Abstract:Background and purposeNon-small cell lung cancer (NSCLC) is a major pathological type of lung cancer and accounts for more than 80% of all cases. In healthcare management, it is challenging to understand the mechanism of NSCLC due to diverse spectra and the limited number of reported data. Selaginella tamariscina is an evergreen perennial plant, hermaphrodite, and used to treat numerous diseases, including NSCLC. In vitro research revealed the therapeutic importance of S. tamariscina in contrast to NSCLC, but the molecular mechanism is still unclear. In the present study, a network pharmacology technique was employed to uncover the active ingredients, their potential targets, and signaling pathways in S. tamariscina for the treatment of NSCLC.MethodsPutative ingredients of S. tamariscina and significant genes of NSCLC were retrieved from the public database after screening. The overlapped targets among S. tamariscina related compounds and NSCLC were predicted using Venn plot. Following that, a compound-target-disease network was constructed using Cytoscape to decipher the mechanism of S. tamariscina for NSCLC. KEGG pathway and GO enrichment analysis were performed to investigate the molecular mechanisms and pathways related to S. tamariscina for NSCLC treatments. Lastly, molecular docking and molecular dynamic simulation analysis were performed to validate the interaction that exists between compounds and target proteins.ResultsThe findings of the current analysis explored the compound–target–pathway network and figured out that Hinokiflavone, Heveaflavone, Neocryptomerin, Isocryptomerin, Apigenin, Sotetsuflavone, and Cryptomerin B decisively contributed to the development of NSCLC by affecting AKT1, EGFR, VEGFA, and GCK3B genes. Later, molecular docking and simulation analysis was conducted to validate the successful activity of the active compounds against potential targets. Lastly, it is concluded that predicted multi-target compounds of S. tamariscina will help in improving the body's sensitivity to NSCLC by regulating the expression of AKT1, EGFR, VEGFA, and GCK3B, which may act as potential therapeutic targets of NSCLC.ConclusionIntegrated network pharmacology and docking analysis revealed that S. tamariscina exerted a promising preventive effect on NSCLC by acting on diabetes-associated signaling pathways. The current findings propose that AKT1, VEGFA, EGFR, and GSK3B genes are promising and viable therapeutic targets to reduce the incidence of NSCLC, thereby exerting potential therapeutic effects in NSCLC. This approach introduces a groundwork for further research on the protective mechanisms of S. tamariscina for NSCLC and applications of network pharmacology in drug discovery.

Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Revealed the Molecular Targets and Potential Mechanism of Nauclea Latifolia in the Treatment of Breast Cancer.

Network Pharmacology and Molecular Docking Integrated Strategy to the Screening of Active Components and Mechanisms of Stephaniae Tetrandrae Radix on Breast Cancer

In silico and in vitro study of bioactive compounds of Nigella sativa for targeting neuropilins in breast cancer

Network Pharmacology and Experimental Validation to Explore the Potential Mechanism of Nigella sativa for the Treatment of Breast Cancer

Integrated network pharmacology, bioinformatics, and molecular docking to explore the mechanisms of berberine regulating autophagy in breast cancer

Network Pharmacology-Based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment

An in-silico investigation and network pharmacology based approach to explore the anti-breast-cancer potential of Tecteria coadunata (Wall.) C. Chr

Potential target and mechanism exploration from α-mangostin against triple-negative breast cancer: An in silico study

A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer

Revealing the molecular mechanism of baohuoside I for the treatment of breast cancer based on network pharmacology and molecular docking

Deciphering the multi-scale mechanism of herbal phytoconstituents in targeting breast cancer: a computational pharmacological perspective

Exploring the mechanism of action bitter melon in the treatment of breast cancer by network pharmacology

Network-Derived Radioresistant Breast Cancer Target with Candidate Inhibitors from Brown Algae: A Sequential Assessment from Target Selection to Quantum Chemical Calculation

Pivotal role of JNK protein in the therapeutic efficacy of parthenolide against breast cancer: Novel and comprehensive evidences from network pharmacology, single-cell RNA sequencing and metabolomics

Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray

THE POTENTIAL EFFECT OF APORPHINE ALKALOIDS FROM NELUMBO NUCIFERA GAERTN. AS ANTI-BREAST CANCER BASED ON NETWORK PHARMACOLOGY AND MOLECULAR DOCKING

Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment

Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells

Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer

Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets